- Academic Editor
Background: Twin pregnancies carry significant fetal, perinatal and maternal risks. Thus, it is important to evaluate clinical outcomes of in vitro fertilization with donor sperm (IVFD) in the first attempt with double cleavage-stage embryos and explore optimal number of day 3 high-quality embryos for the blastocyst transfer on day 5. Methods: We retrospectively identified all IVFD embryo transfers (IVFD-ETs) for the initial time between 2014 and 2021 at our hospital. We mainly analyzed the twin pregnancy rates for double day 3 embryo transfers and clinical outcomes of day 5 blastocyst transfers by prolonged culture with different numbers of day 3 high-quality embryos. Results: Among 1512 IVFD-ETs, 834 were day 3 embryo transfers and 678 were day 5 blastocyst transfers. Our data indicated that the twin pregnancy rates reached up to 40% in the 674 double cleavage-stage embryo transfers and it was not due to the quality of the transferred embryos. For prolonged culture with 2, 3 and 4 day 3 high-quality embryos, the cycle rates of no high-quality blastocysts obtained were 30.43%, 19.80% and 7.91%, respectively. The clinical pregnancy rates were 56.52%, 74.26% and 72.32%, respectively. The twin pregnancies rates were 7.69%, 14.67% and 6.77%, respectively. Conclusions: Transferring double cleavage-stage embryos had high risks of twin pregnancies in the IVFD-ETs. Blastocyst transfer was safe and recommended for the patients with three or more high-quality embryos on day 3.
Infertility affects approximately 15% of couples. The requirement of in vitro fertilization (IVF) treatments using donor semen has gradually increased in recent years. In China, treatments with donor sperm were mainly due to azoospermia and intracytoplasmic sperm injection (ICSI) failures.
It was increasingly believed that the singleton pregnancy was the only desirable outcome of assisted reproductive technology. Nevertheless, the twin pregnancy rates increased by 50–70% in the last three decades [1]. Twin pregnancies carry significant fetal, perinatal and maternal risks. The incidence of virtually each obstetrical complication was more frequent in multiple pregnancies. It has been suggested that the norm be 1 embryo transferred at a time [2].
Embryo quality is a significant factor for achieving a live birth by assisted reproductive technology (ART). However, previous research has mainly focused on the effect of oocyte quality on embryo quality. Recently, the onus for improving embryo quality was also equally shared by the quality of sperm [3]. In women undergoing IVF, the use of donor sperm improved pregnancy outcomes as compared to those using partner sperm. One reason was that donor sperm had better sperm quality compared to partner sperm. Alternatively, the proportion of women who had fertility problems was lower in IVF with donor sperm (IVFD) compared with conventional IVF cycles. There was a high risk of twin pregnancies if double embryos were transferred in the IVFD embryo transfers (IVFD-ETs). Therefore, the aim of this study was to explore the clinical outcomes of IVFD-ETs with double cleavage-stage embryos and identify optimal number of day 3 high-quality embryos for prolonged culture to the blastocyst-stage.
This study included 1512 IVFD-ETs for the initial transfer from January 2014 to
January 2021 at Northwest Women’s and Children’s Hospital. Eight hundred
thirty-four were cleavage-stage embryo transfer which included six hundred
seventy-four double embryo transfers. Double embryo transfers were assigned into
the D3-DET-HH group (transfer of day 3 two high-quality embryos; n = 200),
D3-DET-HL (transfer of day 3 one high-quality and one low-quality embryo; n =
98), and D3-DET-LL (transfer of day 3 two low-quality embryos; n = 138) groups.
Six hundred seventy-eight were blastocyst transfers which included 76 embryo
transfers with no high-quality blastocysts obtained. The blastocyst transfers
were assigned into the D5-ET-2H group (transfers by extended culture to
blastocyst-stage with day 3 two high-quality embryos; n = 46), D5-ET-3H
(transfers by extended culture to blastocyst-stage with day 3 three high-quality
embryos; n = 101) and D5-ET-
The controlled ovarian hyperstimulation (COH) was described previously [4]. Notably, recombinant follicle-stimulating hormone (FSH) or urinary FSH and/or human menopausal gonadotropins were used with daily doses between 100 and 450 IU based on patients’ characteristics as calculated previously [4].
Donor’s semen samples were obtained from Shaanxi Province Human Sperm Bank. The
general procedures for donor recruitment, sperm freezing, and selection of
recipients were in accordance with the standards of National Health and Family
Planning Commission (NHFPC) of the People’s Republic of China. The semen
parameters for donors before freezing are: volume
After 64 to 68 h of culture, the cleavage-stage embryos were scored according to
homogeneous degree of blastomeres, the number of blastomeres and embryo
fragmentation. The high-quality cleavage-stage embryos were graded I and II. The
available cleavage-stage embryos were graded I, II, and III [6]. The
blastocyst-stage embryos were scored according to the stage of development from 1
to 6, the grade of the inner cell mass and the trophectoderm [7]. The
high-quality blastocyst was graded
Patients was given 60 mg progesterone (Xianju Pharmaceutical Co., Ltd., Taizhou, Zhejiang, China) by intramuscular injection or 600 mg progesterone of vaginal micronized daily post embryo transfer. An ET catheter (Cook, Limerick, Ireland) was utilized to place the embryos with the guidance of transabdominal ultrasound. To increase the success rate of embryo placement, the mucus in the cervical os was cleaned in advance with a cotton swab soaked in warm and humid saline. Luteal support was provided for all patients after ET. Clinical pregnancy was characterized as the presence of an intrauterine gestational sac on ultrasonography during the first trimester. Ongoing pregnancy was defined as a clinical pregnancy that continued for at least 12 weeks.
Statistical analysis between groups in the case of continuous variables was
performed with Student’s t test for data with normal distribution.
Non-parametric Mann-Whitney U-test was performed for data with skewed
distribution. Statistical analysis between groups in the case of categorical
variables was expressed as number and percentage and Chi-square test or Fisher
exact test was performed. Forward logistic regression analysis was performed to
determine the risk factors for twin pregnancy. The statistical analysis was
performed with SPSS version 23 (IBM Corp., Armonk, NY, USA). p
The study flow chart is shown in Fig. 1. After excluding subjects with various factors, 1512 women underwent IVFD-ETs for the initial time during the study period. Eight hundred thirty-four were cleavage-stage embryo transfers which included 674 double embryo transfers. Six hundred seventy-eight were blastocyst-stage embryo transfers which included 76 embryo transfers with no high-quality blastocysts obtained.
Study flow chart. IVFD, in vitro fertilization with
donor sperm; ET, embryo transfer; PCOS, polycystic ovary syndrome; ICSI,
intracytoplasmic sperm injection; D3-DET-HH, transfer of day 3 two high-quality
embryos; D3-DET-HL, transfer of day 3 one high-quality and one low-quality
embryo; D3-DET-LL, transfer of day 3 two low-quality embryos; D5-ET-2H, transfers
by extended culture to blastocyst-stage with day 3 two high-quality embryos;
D5-ET-3H, transfers by extended culture to blastocyst-stage with day 3 three
high-quality embryos; D5-ET-
Our data showed no significant differences in the aspects of female age, body
mass index (BMI), basal FSH value and endometrial thickness between D3-SET-H
(transfer of day 3 single high-quality embryos) and D3-SET-L (transfer of day 3
single low-quality embryos groups) (p
Parameter | D3-SET-H | D3-SET-L | p |
No. transfers | 104 | 56 | / |
Female age (years) | 30.16 |
29.32 |
0.237 |
BMI (kg/m |
22.72 |
22.44 |
0.811 |
Basal FSH (mIU/mL) | 7.45 |
8.20 |
0.385 |
No. of retrieved oocytes (n) | 7.00 |
5.57 |
0.024 |
Endometrial thickness (mm) | 11.89 |
11.84 |
0.862 |
Clinical pregnancy (%, n) | 53.85% (56/104)* | 28.57% (16/56)* | 0.002 |
Ongoing pregnancy (%, n) | 50.00% (52/104)* | 28.57% (16/56)* | 0.009 |
Live birth (%, n) | 49.04% (51/104)* | 26.79% (15/56)* | 0.006 |
D3-SET-H, transfer of day 3 single high-quality embryos; D3-SET-L, transfer of day 3 single low-quality embryos; BMI, body mass index; FSH, follicle-stimulating hormone; *significantly different.
The twin pregnancy rates at the initial transfer with double cleavage-stage
embryos reached 41.38% in the IVFD-ETs (Fig. 2). The number of retrieved oocytes
was significantly higher in the D3-DET-HH group than that in the D3-DET-HL and
D3-DET-LL groups (9.99
Proportion of twin pregnancies at initial embryo transfer with double cleavage-stage embryos in the IVFD cycles.
Paramater | D3-DET-HH | D3-DET-HL | D3-DET-LL | p |
Number of transfers | 400 | 176 | 98 | / |
Maternal age (years) | 28.94 |
29.24 |
29.14 |
0.674 |
BMI (kg/m |
21.92 |
21.64 |
22.03 |
0.231 |
Total Gn dosage (IU) | 2214.94 |
2439.06 |
2381.38 |
0.004 |
Stimulation duration (days) | 10.35 |
10.25 |
10.35 |
0.617 |
FSH (mIU/mL) | 6.97 |
7.37 |
7.44 |
0.070 |
Number of oocytes retrieved (n) | 9.99 |
8.38 |
8.64 |
|
Endometrial thickness (mm) | 11.80 |
11.89 |
11.79 |
0.626 |
Clinical pregnancy (%, n) | 75.00 (300/400) |
64.77 (114/176) |
50.51 (50/99) |
|
Twin pregnancies (%, n) | 40.67 (122/300) | 41.23 (47/114) | 46.00 (23/50) | 0.479 |
Ongoing pregnancy (%, n) | 68.75 (275/400) |
62.50 (110/176) |
46.46 (46/99) |
|
Live birth (%, n) | 65.50 (262/400) |
59.66 (105/176) |
45.45 (45/99) |
OR | 95% CI | p | |
Age (years) | 0.981 | 0.933–1.031 | 0.450 |
BMI (kg/m |
1.026 | 0.960–1.096 | 0.447 |
Total Gn dosage (IU) | 1.000 | 1.000–1.000 | 0.770 |
Gn stimulation (days) | 1.024 | 0.912–1.150 | 0.688 |
Basal FSH (mIU/mL) | 1.020 | 0.938–1.109 | 0.641 |
No. of retrieved oocytes (n) | 0.979 | 0.930–1.030 | 0.415 |
OR, odds ratio; 95% CI, 95% confidence interval.
The patients in the D5-ET-2H group were significantly older (29.89
Paramater | D5-ET-2H | D5-ET-3H | D5-ET- |
p |
No. transfers | 46 | 101 | 531 | / |
Female age (years) | 29.89 |
29.54 |
28.78 |
0.047 |
BMI (kg/m |
24.73 |
22.18 |
22.38 |
0.710 |
Basal FSH (mIU/mL) | 7.77 |
7.33 |
6.84 |
0.027 |
No. of retrieved oocytes (n) | 7.83 |
9.23 |
12.15 |
|
Endometrial thickness (mm) | 12.10 |
11.87 |
12.05 |
0.917 |
No high-quality blastocyst obtained (n, %) | 30.43 (14/46) |
19.80 (20/101) |
7.91 (42/531) |
|
Clinical pregnancy (%, n) | 56.52 (26/46) |
74.26 (75/101) |
72.32 (384/531) |
0.023 |
Twin pregnancy (%, n) | 7.69 (2/26) | 14.67 (11/75) |
6.77 (26/384) |
0.022 |
Ongoing pregnancy (%, n) | 54.35 (25/46) | 65.35 (66/101) | 65.91 (350/531) | 0.115 |
Live birth (%, n) | 47.83 (22/46) |
60.40 (61/101) | 63.09 (335/531) |
0.041 |
Clinical outcomes of the study population.
In this research, our data revealed that the clinical pregnancy rate was only 28.57% for single low-quality cleavage-stage embryo transfer. Double embryo transfers have been used to increase the live birth rate in conventional IVF strategy. Thus, double cleavage-stage embryo transfers were previously recommended to ensure ideal success rate on day 3 in our center. The increased number of transferred embryos was associated with a higher incidence of multiple births. Multiple pregnancies increased the incidence of low birth weight, perinatal mortality and congenital malformations [8].
It has been reported that pregnancies conceived with donor sperm had a lower odds of early pregnancy loss and ectopic pregnancy compared to pregnancies conceived with partner sperm [9]. Bortoletto et al. [10] indicated that the women using donor sperm were more likely to have a live birth than those using their partner’s sperm. Thus, multiple births are more likely to occur in the IVFD-ETs than conventional IVF-ETs when double embryos were transferred. A recent meta-analysis indicated that single blastocyst transfer was associated with higher clinical pregnancy and live birth rates compared to single cleavage-stage embryo transfer [11]. Therefore, it is important to evaluate clinical outcomes of double cleavage-stage embryo transfers and identify optimal number of high-quality cleavage-stage embryos for extended culture to blastocyst-stage in the IVFD-ETs.
Our data indicated that clinical pregnancy and live birth rates were significantly improved by adding an extra high or low-quality embryo on day 3. However, the risks of multiple pregnancies were also increased. Previous research also showed that the transfer of an extra poor quality embryo might increase the incidence of a multiple pregnancy [12, 13]. We further analyzed the risk factors for twin pregnancies. Petanovski et al. [14] demonstrated that increased BMI and older age had negative impacts on pregnancy outcomes. High serum FSH was associated with low-quality oocyte formation and a reduced pregnancy rate [15]. Martin et al. [16] indicated it existed a significant negative correlation between gonadotrophin requirements and pregnancy rates. Ovarian stimulation was considered as a risk factor for poor clinical outcomes. Earlier studies indicated that it could impact ideal delivery rates after fresh transfers when the number of retrieved oocytes was between 6 and 15 [17, 18]. Nevertheless, we observed that none of these risk factors was independently associated with twin pregnancies in the IVFD-ETs.
Multiple births could be effectively reduced by transferring a single blastocyst [19]. It carried a risk of absent blastocyst formation if extended culture to blastocyst-stage was performed. The blastocyst formation could be affected by various factors. Janny et al. [20] showed that the blastulation rate decreased due to a high incidence of embryo arrest at morula stage in patients above age 30. Meanwhile, the number of high-quality cleavage-stage embryos was also one of the key determinants of achieving the ideal number of blastocysts. Thus, it was worth considering the optimal number of day 3 high-quality embryos for blastocyst transfer in the IVFD cycles.
It has been reported that the blastocyst transfers were associated with high implantation rate and low multiple births rate [21]. Nevertheless, it was difficult to predict that the blastocysts could be formed. Rijnders et al. [22] concluded that evaluation of day 3 embryo morphology had limited predictive value for subsequent blastocyst formation. It has been reported that the blastulation rate was impaired when the embryo morphology was compromised on day 3 [22]. Braga et al. [23] demonstrated that transferring poor cleavage-stage embryos was a better option than transferring embryos at the blastocyst-stage. Thus, it should be careful in recommending the strategy of blastocyst culture for some patients.
Our data showed that the cycle rate of poor quality blastocyst obtained was
beyond 30% for cycles with only two good D3 embryos. For such patients, extended
culture and blastocyst-stage embryo transfers had negative effects on the
clinical outcomes compared with cleavage-stage embryo transfers, although the
twin pregnancy rate was significantly decreased. We observed that the clinical
outcomes were comparable either by transferring single cleavage-stage
high-quality embryo or culturing the embryos to D5 for transfer with two good D3
embryos. For cycles with
In conclusion, for patients with
Our study demonstrated that transferring double cleavage-stage embryos had a high risk of twin pregnancies in the IVFD-ETs. Blastocyst transfer was safe and recommended for the patients with three or more high-quality embryos on day 3.
IVFD, in vitro fertilization with donor sperm; ETs, embryo transfers; BMI, body mass index; FSH, follicle-stimulating hormone; Gn, gonadotropin; CI, confidence interval; OR, odds ratio.
Data is available on request corresponding author due to privacy and ethical restrictions.
ML and JS designed the research. ML and XX performed the research. XX analyzed the data. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.
This research was approved by the ethics committee of Northwest Women’s and Children’s Hospital (No. 2022007). Patient consent was not required due to the retrospective nature of the study.
Not applicable.
This project was supported by Shaanxi Technology Committee Industrial Public Relation Project (Project Number: 2023-YBSF-034).
The authors declare no conflict of interest.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.